Predictive Oncology Reports Year End 2022 Financial Results and Provides Business Update
March 21, 2023 17:15 ET
|
Predictive Oncology Inc.
EAGAN, Minn., March 21, 2023 (GLOBE NEWSWIRE) -- Predictive Oncology Inc. (Nasdaq: POAI), a science-driven company leveraging its proprietary artificial intelligence and machine learning...
Predictive Oncology and Cancer Research Horizons have partnered to pursue development of cancer drugs
March 17, 2023 07:00 ET
|
Predictive Oncology Inc.
EAGAN, Minn., March 17, 2023 (GLOBE NEWSWIRE) -- Predictive Oncology Inc. (NASDAQ: POAI) together with Cancer Research Horizons, the innovation engine at the core of the world’s largest private...
Predictive Oncology Announces Distribution of Series F Preferred Stock to Holders of its Common Stock
March 16, 2023 17:15 ET
|
Predictive Oncology Inc.
EAGAN, Minn., March 16, 2023 (GLOBE NEWSWIRE) -- Predictive Oncology Inc. (NASDAQ: POAI) (“Predictive Oncology” or the “Company”), today announced that its Board of Directors declared a dividend of...
Predictive Oncology Engages LifeSci Advisors as Strategic Investor Relations Partner
March 14, 2023 08:30 ET
|
Predictive Oncology Inc.
EAGAN, Minn., March 14, 2023 (GLOBE NEWSWIRE) -- Predictive Oncology (Nasdaq: POAI), a science driven company leveraging its proprietary artificial intelligence and machine learning capabilities,...
Predictive Oncology Issues Letter to Shareholders
March 09, 2023 08:30 ET
|
Predictive Oncology Inc.
EAGAN, Minn., March 09, 2023 (GLOBE NEWSWIRE) -- Predictive Oncology (Nasdaq: POAI), a science-driven company leveraging its proprietary artificial intelligence and machine learning capabilities to...
Predictive Oncology and Cvergenx announce partnership to develop the first-ever genomics-based approach to precision radiation therapy and drug discovery using artificial intelligence
February 23, 2023 08:30 ET
|
Predictive Oncology Inc.
EAGAN, Minn., Feb. 23, 2023 (GLOBE NEWSWIRE) -- Predictive Oncology Inc. (NASDAQ: POAI) and Cvergenx, Inc. today announced an agreement to form a strategic partnership that has the potential to...
Predictive Oncology launches ACE program to partner with academic and research institutions to advance their drug discovery initiatives
February 21, 2023 08:30 ET
|
Predictive Oncology Inc.
EAGAN, Minn., Feb. 21, 2023 (GLOBE NEWSWIRE) -- Predictive Oncology Inc. (NASDAQ: POAI) today announced the launch of ACE (Accelerating Compound Exploration), a program to advance the oncology drug...
Predictive Oncology Appoints Pamela Bush, Ph.D., MBA, as Chief Business Officer
February 03, 2023 08:31 ET
|
Predictive Oncology Inc.
EAGAN, Minn., Feb. 03, 2023 (GLOBE NEWSWIRE) -- Predictive Oncology Inc. (NASDAQ: POAI) is pleased to announce the appointment of Pamela Bush, Ph.D., MBA, as Chief Business Officer. Dr. Bush will...
Pioneer of Computational Biology Joins the Scientific Advisory Board of Predictive Oncology
January 12, 2023 08:30 ET
|
Predictive Oncology Inc.
EAGAN, Minn., Jan. 12, 2023 (GLOBE NEWSWIRE) -- Predictive Oncology Inc. (NASDAQ: POAI) today announced the appointment of Robert F. Murphy, Ph.D., to the company’s Scientific Advisory Board where...
Distinguished Innovator in Genomics Joins the Scientific Advisory Board of Predictive Oncology
December 13, 2022 08:30 ET
|
Predictive Oncology Inc.
EAGAN, Minn., Dec. 13, 2022 (GLOBE NEWSWIRE) -- Predictive Oncology Inc. (NASDAQ: POAI) today announced the appointment of Marc Malandro, Ph.D., to the company’s Scientific Advisory Board where he...